CTNNA1 inhibits tumor metastasis and cell growth through inhibition of EMT in bladder cancer, and the reversal of the oncogenic effect of EMT by miR-429 and Setd2 in colorectal and pancreatic cancers is also associated with CTNNA1. This evidence concerns the gene CTNNA1 and urinary bladder carcinoma.